| Date | Time | Source | Headline | Symbol | Company |
| 04/21/2009 | 5:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/21/2009 | 4:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/21/2009 | 4:05PM | Business Wire | Gilead Sciences Announces Record First Quarter 2009 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 04/21/2009 | 9:30AM | PR Newswire (US) | HotPennyStocks.biz Issues Technical Trade Alerts On Hot Stocks Today: GILD, HCBK, DD, DAL, COH, & COF | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2009 | 3:50PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2009 | 10:45AM | Dow Jones News | US Supreme Court Won't Hear Tuna Fish-Mercury Case | NASDAQ:GILD | Gilead Sciences Inc. |
| 04/20/2009 | 10:40AM | PR Newswire (US) | Beacon Equity Issues Trade Alerts on Pharmaceutical Leaders: LLY, BIIB, GILD, AMGN, LIFE, TEVA | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2009 | 6:19AM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/17/2009 | 4:15PM | Business Wire | Gilead Sciences Completes Acquisition of CV Therapeutics | NASDAQ:GILD | Gilead Sciences Inc |
| 04/17/2009 | 8:30AM | Business Wire | Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV | NASDAQ:GILD | Gilead Sciences Inc |
| 04/16/2009 | 4:21PM | Dow Jones News | DEALWATCH: Dull Pharma JV May Become Alluring Spin-Off, Sale | NASDAQ:GILD | Gilead Sciences Inc. |
| 04/15/2009 | 4:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/15/2009 | 8:30AM | Business Wire | Gilead Sciences Successfully Completes Tender Offer for Shares of CV Therapeutics With Over 88 Percent of Shares Tendered | NASDAQ:GILD | Gilead Sciences Inc |
| 04/14/2009 | 4:15PM | Business Wire | Gilead Sciences to Release First Quarter 2009 Financial Results on Tuesday, April 21, 2009 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/14/2009 | 10:37AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/13/2009 | 1:04PM | Dow Jones News | EARNINGS PREVIEW: Biotechs Hit By Credit Woes; Deals Seen | NASDAQ:GILD | Gilead Sciences Inc. |
| 04/13/2009 | 8:30AM | Business Wire | Phase III Data for Gilead Sciences’ Darusentan Accepted as Late-Breaker Presentation at ASH 2009 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/09/2009 | 8:53AM | Marketwired | TheFortuneFinancial.com Initializes Free Analyst Research on DELL, TTWO, GILD and CTIC | NASDAQ:GILD | Gilead Sciences Inc |
| 04/06/2009 | 6:08PM | Dow Jones News | Gilead Reviews Teva's Generic Application, May File Suit | NASDAQ:GILD | Gilead Sciences Inc. |
| 04/06/2009 | 5:00PM | Business Wire | Gilead Sciences Announces Notification of ANDA Filing for Atripla® | NASDAQ:GILD | Gilead Sciences Inc |
| 04/03/2009 | 2:01PM | PR Newswire (US) | Beacon Equity Issues Trade Alerts on Market Movers: BBI, SVNT, SI, GILD, CHRS, RIMM | NASDAQ:GILD | Gilead Sciences Inc |
| 04/03/2009 | 1:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/02/2009 | 5:22PM | Business Wire | Phase III Study of Gilead’s Darusentan for Resistant Hypertension Meets Primary Endpoints | NASDAQ:GILD | Gilead Sciences Inc |
| 04/01/2009 | 3:52PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/31/2009 | 6:31PM | Business Wire | Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period | NASDAQ:GILD | Gilead Sciences Inc |
| 03/31/2009 | 9:31AM | PR Newswire (US) | Stock Alerts for GE, PNC, GILD, BMY, and NTES Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 03/31/2009 | 6:31AM | Dow Jones News | Aurobindo Gets Tentative US OK For Combination Tablet | NASDAQ:GILD | Gilead Sciences Inc. |
| 03/31/2009 | 1:58AM | Dow Jones News | Matrix Laboratories Gets Tentative FDA OK For Generic Truvada | NASDAQ:GILD | Gilead Sciences Inc. |
| 03/30/2009 | 7:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/24/2009 | 4:15PM | Business Wire | Gilead Initiates Phase II Clinical Trial of Cicletanine for the Treatment of Pulmonary Arterial Hypertension | NASDAQ:GILD | Gilead Sciences Inc |